Transforming Pharma Procurement. Together.
Eurofins BioPharma Services looks forward to meeting you at the ProcureCon PHARMA meeting in Frankfurt, Germany from March 19-20, 2019.
You are cordially invited to join Eurofins BioPharma Services Round-Table Discussion, chaired by our Vice President Commercial Operations, Mr. Tracy Hendershott. Round-tables are organized on the second day of the conference (March 20, 2019), from 10.20-11.00 in the plenary room.
Tracy has three decades of ever-increasing responsibility in the Clinical Trial arena, both in the CRO and Central Laboratory fields. He provides leadership, strategy and coordination of company sales, marketing and contracts and proposals functions. Tracy is based in the United States in his current role as Vice President of Commercial Operations at Eurofins BioPharma Services.
Stop by our Lounge Space #15 to meet with the team and discuss how end-to-end integrated lab solutions can take your procurement efforts to the next level!
Eurofins BioPharma Services: End-to-End Integrated Lab Performance
Eurofins BioPharma Services, Laboratory Testing is a full-service global organization with dedicated testing facilities for Early Clinical Development, Central Laboratory Services, Bioanalytical Services, Virology and Immunology Testing Services, and Anatomic Pathology and Genomics Services. As a division of the Eurofins Scientific Group, our sole and only focus is clinical laboratory analysis.
Eurofins is purely focused on laboratory testing in support of improving quality of lives. The three main sectors are biopharmaceuticals, food, and environment. The Group intends to continue to develop and acquire the most comprehensive range of state-of-the-art analytical technologies as well as expand its geographical reach in order to support its clients' increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world. Eurofins Laboratories around the world are helping to improve cancer treatments, fight the growing problem of antibiotic resistance, catch criminals, safeguard the health of bees, ensure our food and water is safe, determine paternity, and beat viruses, such as Zika.
With Eurofins Central Laboratory acting as the hub, in a hub and spokes model, clients will have access to all specialized Eurofins BioPharma Services divisions within the Eurofins Group. This includes standalone divisions focused on Clinical Development, e.g. Anatomical Pathology, Genomics, Virology, Allergy, Immunology, Bioanalytical Services, and the Eurofins Phase 1 Unit. In support of full-service central laboratory contracts, Eurofins will be providing access to all these units of specialization with single source contracting and invoicing to Clients.
In addition, beyond the clinical phase of drug development efforts, Eurofins has specialized divisions focusing on Discovery as well as compound focused analysis in GMP/GLP environments (Eurofins BioPharma Product Testing). The Eurofins Group has capabilities to provide analytical services from compound discovery, through clinical research phases, and all the way to post approval/marketing.
With the largest network of BioPharma Laboratories in the world, we offer the most comprehensive testing in the industry. This network provides our clients with access to scientists of all laboratory specializations within one organization and allows us to provide highly consultative services. With regard to any other clinical trial laboratories, Eurofins is unparalleled in its portfolio of testing, its innovative technology and its history of having a global presence.
